65 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
12
Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligands.
Korea University
4
Unprecedented Binding Mode of Hydroxamate-Based Inhibitors of Glutamate Carboxypeptidase II: Structural Characterization and Biological Activity.
Academy of Sciences of The Czech Republic
11
Preparation and Evaluation of Radiolabeled Antibody Recruiting Small Molecules That Target Prostate-Specific Membrane Antigen for Combined Radiotherapy and Immunotherapy.
Mcmaster University
11
Design of highly potent urea-based, exosite-binding inhibitors selective for glutamate carboxypeptidase II.
Academy of Sciences of The Czech Republic
3
Reversible disulfide formation of the glutamate carboxypeptidase II inhibitor E2072 results in prolonged systemic exposures in vivo.
Johns Hopkins School of Medicine
12
Synthesis and evaluation of constrained phosphoramidate inhibitors of prostate-specific membrane antigen.
Washington State University
1
DUPA conjugation of a cytotoxic indenoisoquinoline topoisomerase I inhibitor for selective prostate cancer cell targeting.
Purdue University
20
Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery.
Academy of Sciences of The Czech Republic
3
d-Thiolactones as prodrugs of thiol-based glutamate carboxypeptidase II (GCPII) inhibitors.
Johns Hopkins University
13
Preparation of asymmetric urea derivatives that target prostate-specific membrane antigen for SPECT imaging.
Kyoto University
20
Radiofluorinated derivatives of 2-(phosphonomethyl)pentanedioic acid as inhibitors of prostate specific membrane antigen (PSMA) for the imaging of prostate cancer.
Bayer Healthcare
22
Design, synthesis, and pharmacological evaluation of glutamate carboxypeptidase II (GCPII) inhibitors based on thioalkylbenzoic acid scaffolds.
Eisai
7
Phosphoramidate derivatives of hydroxysteroids as inhibitors of prostate-specific membrane antigen.
Washington State University
3
Design and synthesis of a siderophore conjugate as a potent PSMA inhibitor and potential diagnostic agent for prostate cancer.
University of Notre Dame
3
Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated alpha-linked acidic dipeptidase.
Zeneca Pharmaceuticals
10
Novel substrate-based inhibitors of human glutamate carboxypeptidase II with enhanced lipophilicity.
Academy of Sciences of The Czech Republic
4
Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigen.
Washington State University
17
The discovery and structure-activity relationships of indole-based inhibitors of glutamate carboxypeptidase II.
Eisai Research Institute
3
A targeted low molecular weight near-infrared fluorescent probe for prostate cancer.
Washington State University
43
Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studies.
Institutions
19
A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer.
Molecular Insight Pharmaceuticals
11
Multivalent scaffolds for affinity maturation of small molecule cell surface binders and their application to prostate tumor targeting.
Justus-Liebig-Universitat Giessen
3
Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer.
Institutions
17
Prodrugs Targeting Prostate-Specific Membrane Antigen against Prostate Cancer.
National and Kapodistrian University of Athens (NKUA)
1
PSMA-Guided PROTAC Degraders for Tumor-Specific Protein Degradation in Prostate Cancer.
Ocean University of China
3
Synthesis and Preclinical Evaluation of a Bispecific PSMA-617/RM2 Heterodimer Targeting Prostate Cancer.
German Cancer Research Centre (DKFZ)
4
Design, synthesis and evaluation of novel prostate-specific membrane antigen-targeted aryl [18F]fluorosulfate PET tracers.
Fudan University
11
The molecular pruning of a phosphoramidate peptidomimetic inhibitor of prostate-specific membrane antigen.
San Francisco State University
40
Discovery of Glutamate Carboxypeptidase III Ligands to Compete the Uptake of [177Lu]Lu-PSMA-617 in Healthy Organs.
Philochem
2
PSMA-targeted small-molecule drug-conjugates with valine-citrulline and phosphoramidate cleavable linkers.
Washington State University
5
-Alkyl Carbamoylimidazoles as Versatile Synthons for the Synthesis of Urea-Based PSMA Inhibitors.
University of Alberta
12
Design and Characterization of Squaramic Acid-Based Prostate-Specific Membrane Antigen Inhibitors for Prostate Cancer.
Beijing Normal University
18
Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA Inhibitors.
German Cancer Research Center
4
PSMA-targeted low-molecular double conjugates for diagnostics and therapy.
Lomonosov Moscow State University
5
PSMA-targeted small-molecule docetaxel conjugate: Synthesis and preclinical evaluation.
Lomonosov Moscow State University
17
Synthesis and initial in vitro evaluation of PSMA-targeting ligands with a modified aromatic moiety at the lysine ε-nitrogen atom.
Lomonosov Moscow State University
25
Synthesis and Biological Evaluation of PSMA Ligands with Aromatic Residues and Fluorescent Conjugates Based on Them.
Lomonosov Moscow State University
3
Dipeptide inhibitors of the prostate specific membrane antigen (PSMA): A comparison of urea and thiourea derivatives.
King'S College London
16
Synthesis and biological evaluation of hydroxamate-Based inhibitors of glutamate carboxypeptidase II.
Guilford Pharmaceuticals
14
Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor.
Guilford Pharmaceuticals
4
Phosphonate and phosphinate analogues of N-acylated gamma-glutamylglutamate. potent inhibitors of glutamate carboxypeptidase II.
Guilford Pharmaceuticals
29
Design and pharmacological activity of phosphinic acid based NAALADase inhibitors.
Guilford Pharmaceuticals
9
Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase).
TBA
8
Synthesis and evaluation of novel radioiodinated PSMA targeting ligands for potential radiotherapy of prostate cancer.
Beijing Normal University
17
Design, synthesis, and proposed active site binding analysis of monocyclic 2-azetidinone inhibitors of prostate specific antigen.
University of Oxford
4
Synthesis and biological evaluation of PSMA-targeting paclitaxel conjugates.
Lomonosov Moscow State University
19
Novel β- and γ-Amino Acid-Derived Inhibitors of Prostate-Specific Membrane Antigen.
Korea University
8
Structural and computational basis for potent inhibition of glutamate carboxypeptidase II by carbamate-based inhibitors.
Institute of Biotechnology of The Czech Academy of Sciences
20
2-Aminoadipic Acid-C(O)-Glutamate Based Prostate-Specific Membrane Antigen Ligands for Potential Use as Theranostics.
University of Illinois At Chicago
4
Synthesis of novel multivalent fluorescent inhibitors with high affinity to prostate cancer and their biological evaluation.
Yonsei University College of Medicine
10
Synthesis of acyclic and dehydroaspartic acid analogues of Ac-Asp-Glu-OH and their inhibition of rat brain N-acetylated alpha-linked acidic dipeptidase (NAALA dipeptidase).
University of Minnesota
7
Discovery of a para-Acetoxy-benzyl Ester Prodrug of a Hydroxamate-Based Glutamate Carboxypeptidase II Inhibitor as Oral Therapy for Neuropathic Pain.
Academy of Sciences of The Czech Republic
10
SUBSTITUTED PYRAZOLYL COMPOUNDS AND METHODS OF USE THEREOF
Chinook Therapeutics Canada
15
N-SUBSTITUTED INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
Mindset Pharma
27
IMIDAZO[1,2-a]PYRAZINE OR PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE AND USE THEREOF
Tencent Technology (Shenzhen)
217
Substituted benzoimidazoles and imidazo[4,5-c]pyridines for treating certain leukemias
Terns